Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

PURPOSE: Anti-GD2 monoclonal antibody (MoAb) combined with granulocyte-macrophage colony-stimulating factor (GM-CSF) has shown efficacy against neuroblastoma (NB). Prognostic variables that could influence clinical outcome were explored. PATIENTS AND METHODS: One hundred sixty-nine children diagnose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheung, Nai-Kong V., Cheung, Irene Y., Kushner, Brian H., Ostrovnaya, Irina, Chamberlain, Elizabeth, Kramer, Kim, Modak, Shakeel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434986/
https://ncbi.nlm.nih.gov/pubmed/22869886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.41.3807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados